EMMI
USPTO Trademark Record · Serial No. 75899125
Trademark details
It was initially claimed by Glaxo Wellcome Inc. on 20000120.
That brand applies to the following goods and services:Health care financial analysis and consultation services, namely, providing employers and managed care organizations information on health care costs associated with irritable bowel syndrome and on cost savings associated with treatments for irritable bowel syndrome, by using actuarial models to estimate direct medical costs and lost productivity costs due to irritable bowel syndrome, Health care consultation services.
Currently that trademark is represented by trademark attorney(s): Maury M. Tepper.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the EMMI trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
